Telenor
17.3.2021 08:35:41 CET | Globenewswire | Press release
(Fornebu, 17 March 2021) Jukka Leinonen, the CEO of Telenor’s Finnish company DNA, is appointed Head of Telenor Group’s Nordic Cluster full-time from autumn 2021. He continues as Executive Vice President and a member of Telenor Group’s Executive Management, reporting to Sigve Brekke, the President & CEO of Taelenor Group.
Leinonen, who currently holds the role as Head of the Telenor Group’s Nordic Cluster part-time, will continue in his roles as chair of Telenor Sweden, Telenor Denmark, and Telenor Connexion. The search for a new CEO of DNA starts immediately. Once the new CEO of DNA commences, Leinonen will take on the position as chair of DNA.
"Jukka Leinonen has been successfully heading our Nordic Cluster since 2019, developing the co-operation of its business units, enabling synergies, driving growth, and creating value for our customers across the region. It is now time to accelerate the Nordic co-operation further and explore the untapped potential. I am very pleased that Jukka now will lead this work full-time," says Sigve Brekke, President & CEO, Telenor Group.
Leinonen joined DNA as Senior Vice President, Corporate Business in 2010 and was appointed CEO of DNA in 2013. Since 2019, he has additionally headed Telenor Group´s Nordic Cluster as Executive Vice President of Telenor Group. He has previously held various senior management positions in corporate business sales, marketing, and product management at TeliaSonera.
Media contact:
Tormod Sandstø | tormod.sandsto@telenor.com | tel: +47 90 94 32 15
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
Chery Group18.4.2026 15:54:00 CEST | Press release
iCAUR V27 Secures CATARC L3 Off-Road Certification, Solidifying Its New Energy Off-Road Capability with Robust Technology
Sanofi Winthrop Industrie18.4.2026 12:00:00 CEST | Press release
Press Release: ESCMID: Sanofi's Nuvaxovid COVID-19 vaccine showed better tolerability than mNEXSPIKE in head-to-head study
Organizing Committee of the 2026 Fujian Provincial Conference on the Development of Cultural and Tourism Economy18.4.2026 06:50:27 CEST | Press release
2026 Fujian Provincial Conference on Development of Cultural, Tourism Economy opens on Apr. 17 in Zhangzhou, SE China's Fujian
Evaxion17.4.2026 21:10:00 CEST | Press release
Evaxion’s AI-Immunology™ platform demonstrates 86% vaccine target precision in phase 2 personalized cancer vaccine trial
Zymeworks Inc.17.4.2026 21:00:00 CEST | Press release
Zymeworks Presents New Preclinical Data at AACR 2026 Highlighting Broad Antibody-Drug Conjugate Programs Including Novel RAS-Targeting Platform
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
